Duncker Streett & Co. Inc. lessened its position in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 1.3% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 29,372 shares of the medical research company’s stock after selling 400 shares during the quarter. Thermo Fisher Scientific makes up about 1.7% of Duncker Streett & Co. Inc.’s holdings, making the stock its 6th largest position. Duncker Streett & Co. Inc.’s holdings in Thermo Fisher Scientific were worth $5,557,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Amalgamated Bank raised its stake in shares of Thermo Fisher Scientific by 57.0% during the 2nd quarter. Amalgamated Bank now owns 44,921 shares of the medical research company’s stock worth $7,837,000 after buying an additional 16,308 shares during the last quarter. BB&T Securities LLC raised its stake in shares of Thermo Fisher Scientific by 4.4% during the 1st quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock worth $13,798,000 after buying an additional 3,819 shares during the last quarter. Mutual of America Capital Management LLC raised its stake in shares of Thermo Fisher Scientific by 2.1% during the 2nd quarter. Mutual of America Capital Management LLC now owns 47,728 shares of the medical research company’s stock worth $8,327,000 after buying an additional 977 shares during the last quarter. Mitchell Capital Management Co. raised its stake in Thermo Fisher Scientific by 40.3% in the 2nd quarter. Mitchell Capital Management Co. now owns 44,940 shares of the medical research company’s stock valued at $7,841,000 after purchasing an additional 12,910 shares during the last quarter. Finally, State Board of Administration of Florida Retirement System raised its stake in Thermo Fisher Scientific by 0.9% in the 2nd quarter. State Board of Administration of Florida Retirement System now owns 580,712 shares of the medical research company’s stock valued at $101,317,000 after purchasing an additional 5,213 shares during the last quarter. 83.78% of the stock is owned by institutional investors and hedge funds.

In other news, VP Seth H. Hoogasian sold 4,140 shares of the business’s stock in a transaction dated Monday, August 28th. The stock was sold at an average price of $177.80, for a total transaction of $736,092.00. Following the completion of the sale, the vice president now owns 25,518 shares in the company, valued at approximately $4,537,100.40. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, VP Peter E. Hornstra sold 3,894 shares of the business’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $185.18, for a total value of $721,090.92. Following the sale, the vice president now owns 19,751 shares of the company’s stock, valued at approximately $3,657,490.18. The disclosure for this sale can be found here. Insiders have sold a total of 60,420 shares of company stock valued at $11,308,477 in the last quarter. Company insiders own 0.49% of the company’s stock.

Several research analysts recently weighed in on the stock. Zacks Investment Research raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $215.00 target price for the company in a research note on Tuesday, October 31st. Leerink Swann reissued a “buy” rating on shares of Thermo Fisher Scientific in a research note on Monday, October 30th. Deutsche Bank AG set a $226.00 target price on shares of Thermo Fisher Scientific and gave the company a “buy” rating in a research note on Thursday, October 26th. Jefferies Group LLC reissued a “hold” rating and issued a $195.00 target price on shares of Thermo Fisher Scientific in a research note on Thursday, September 28th. Finally, Goldman Sachs Group, Inc. (The) assumed coverage on shares of Thermo Fisher Scientific in a research note on Tuesday, September 26th. They issued a “buy” rating and a $225.00 target price for the company. One analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $205.71.

TRADEMARK VIOLATION NOTICE: This news story was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this news story on another website, it was illegally copied and republished in violation of US & international trademark & copyright laws. The correct version of this news story can be accessed at https://www.thecerbatgem.com/2017/11/18/duncker-streett-co-inc-sells-400-shares-of-thermo-fisher-scientific-inc-tmo.html.

Thermo Fisher Scientific Inc (NYSE TMO) opened at $190.17 on Friday. Thermo Fisher Scientific Inc has a one year low of $139.07 and a one year high of $201.20. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. The company has a market cap of $76,030.00, a PE ratio of 20.78, a PEG ratio of 1.73 and a beta of 1.08.

Thermo Fisher Scientific (NYSE:TMO) last posted its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 EPS for the quarter, beating the Zacks’ consensus estimate of $2.24 by $0.07. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.03 billion. During the same quarter in the prior year, the company posted $2.03 EPS. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. sell-side analysts forecast that Thermo Fisher Scientific Inc will post 9.36 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Stockholders of record on Friday, December 15th will be paid a dividend of $0.15 per share. This represents a $0.60 dividend on an annualized basis and a dividend yield of 0.32%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s dividend payout ratio is currently 10.19%.

Thermo Fisher Scientific Profile

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Stock Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related stocks with our FREE daily email newsletter.